Vivace Therapeutics Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
6

- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$30M
- Investors
-
8
Vivace Therapeutics General Information
Description
Developer of a small molecule drug discovery and development firm intended to bring novel therapies to treat cancer patients. The company is built on innovative science in novel pathways and leverages research from leading academic laboratories by developing therapeutics that could work alone or in combination with other drugs, enabling healthcare professionals to help patients to conquer cancer.
Contact Information
Website
www.vivacetherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 2929 Campus Drive
- Suite 150
- San Mateo, CA 94403
- United States
+1 (858) 000-0000
Vivace Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC (Series C) | 16-Dec-2020 | $30M | 0000 | 00000 | Completed | Startup |
2. Early Stage VC (Series B) | 28-Jun-2017 | 0000 | 0000 | 0000 | Completed | Startup |
1. Early Stage VC (Series A) | 20-Jan-2015 | $15M | $15M | 0000 | Completed | Startup |
Vivace Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 000 |
Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Series A | 15,000,000 | $0.001000 | $0.08 | $1 | $1 | 1x | $1 | 29.87% |
Vivace Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a small molecule drug discovery and development firm intended to bring novel therapies to treat cancer pati
Drug Discovery
San Mateo, CA
6
As of 2023
0000
0000
0000-00-00
00000000000
0000
Vivace Therapeutics Competitors (57)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Apexigen | Formerly VC-backed | San Carlos, CA | 00 | 00000 | 000000000 | 00000 |
000000000 00000000 | Venture Capital-Backed | Rockville, MD | 0 | 000.00 | 0000000000 0 | 000.00 |
000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
00000 | Formerly VC-backed | Boston, MA | 00 | 00000 | 000000&0 | 00000 |
00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
Vivace Therapeutics Patents
Vivace Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4061364-A1 | Heteroaryl compounds | Pending | 20-Nov-2019 | 0000000000 | |
AU-2020257207-A1 | Bicyclic compounds | Pending | 16-Apr-2019 | 0000000000 | |
CA-3137025-A1 | Bicyclic compounds | Pending | 16-Apr-2019 | 0000000000 | |
EP-3956033-A1 | Bicyclic compounds | Pending | 16-Apr-2019 | 0000000000 | |
EP-3956033-A4 | Bicyclic compounds | Pending | 16-Apr-2019 | C07D305/06 | 0 |
Vivace Therapeutics Executive Team (7)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Sofie Qiao Ph.D | Co-Founder, President, Chief Executive Officer and Board Member | ||
Bin Liu Ph.D | Scientific Co-Founder | ||
Kun-Liang Guan Ph.D | Scientific Co-Founder | ||
Andrei Konradi Ph.D | Head of Chemistry | ||
Leonard Post Ph.D | Chief Scientific Officer & Board Member |
Vivace Therapeutics Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Edward Hu | Vivace Therapeutics | Board Member | 000 0000 |
Jun Wu | Vivace Therapeutics | Board Member | 000 0000 |
Leonard Post Ph.D | Self | Chief Scientific Officer & Board Member | 000 0000 |
Norman Zhou Ph.D | Self | Board Member | 000 0000 |
Sofie Qiao Ph.D | Vivace Therapeutics | Co-Founder, President, Chief Executive Officer and Board Member | 000 0000 |
Vivace Therapeutics Signals
Vivace Therapeutics Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
6 Dimensions Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Boxer Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
RA Capital Management | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Cenova Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Sequoia Capital China | Venture Capital | Minority | 000 0000 | 000000 0 |